down arrow

Health.Global

  • Market Cap: Mid Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE075I01017
  • NSEID: HCG
  • BSEID: 539787
INR
530.75
3.75 (0.71%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 93.52 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Healthcare Global Enterprises Ltd stock-summary
stock-summary
Healthcare Global Enterprises Ltd
Mid Cap
Hospital & Healthcare Services
Healthcare Global Enterprises Limited was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a Private Limited Company. The name of the Company was changed to HealthCare Global Enterprises Private Limited on November 14, 2005. Thereafter, it was converted into a Public Limited Company and the name of the Company was changed to Healthcare Global Enterprises Limited on July 5, 2006.
Company Coordinates stock-summary
Company Details
HCG Tower No 8 Kalinga Rao Rd, Sampangi Rama Nagar Bangalore Karnataka : 560027
stock-summary
Tel: 91-80-4660-7700
stock-summary
sunumanuel@hcgoncology.com
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 139.39 Cr
Number of Shares
13.94 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
08-Aug-2024
13.94
139.39
38791
10
Issued under ESOP Scheme
26-Jun-2024
13.93
139.35
30000
10
Issued under ESOP Scheme
08-Feb-2024
13.93
139.29
10400
10
Issued under ESOP Scheme
09-Nov-2023
13.93
139.28
24125
10
Issued under ESOP Scheme
18-Aug-2023
13.93
139.26
38500
10
Issued under ESOP Scheme
10-Aug-2023
13.92
139.22
59350
10
Issued under ESOP Scheme
09-Feb-2023
13.91
139.12
23125
10
Issued under ESOP Scheme
10-Nov-2022
13.91
139.09
12175
10
Issued under ESOP Scheme
10-Aug-2022
13.91
139.08
64770
10
Issued under ESOP Scheme
26-May-2022
13.9
139.02
4000
10
Issued under ESOP Scheme
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

3.0889

Mutual Funds

Held by 9 Schemes (10.04%)

FIIs

Held by 85 FIIs (2.77%)

Promoter with highest holding

Aceso Company Pte. Ltd. (60.35%)

Highest Public shareholder

Tata Mutual Fund - Tata Small Cap Fund (3.35%)

Individual Investors Holdings

9.6%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
BASAVALINGA AJAIKUMAR SADASHIVAIAH
Chairman/ED & CEO
4.09 cr
Siddharth Patel
Non Executive Director / Nomin
0
Anjali Ajaikumar Rossi
Executive Director
79.5 lacs
Geet Mathur
Independent Non Exe. Director
12.4 lacs
RAJAGOPALAN RAGHAVAN
Independent Non Exe. Director
11.2 lacs
Pradip M. Kanakia
Independent Non Exe. Director
8.3 lacs
Meghraj Arvindrao Gore
Whole Time Director & CEO
3.15 cr
AMIT SONI
Non Executive Director / Nomin
0
Rajiv Maliwal
Independent Non Exe. Director
0
SUNU MANUEL
Company Sec. & Compli. Officer
52.5 lacs
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Income from Medical Services
507.27
86.44%
Medical and Non-Medical Items
72.53
12.36%
Other Operating Income
7.07
1.20%
 
86.44
Income from Medical Services
13.56
Income from Medical Services
12.36
Medical and Non-Medical Items
87.64
Medical and Non-Medical Items
1.2
Other Operating Income
98.8
Other Operating Income
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
559 Cr
(Quarterly Results - Dec 2024)
Net Profit:
7 Cr
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 7,399 Cr (Mid Cap)

stock-summary
P/E

133.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.47

stock-summary
Return on Equity

6.24%

stock-summary
Price to Book

8.53